G Model
PHYTOL 933 1–8
8
D. Zhang et al. / Phytochemistry Letters xxx (2015) xxx–xxx
488
489
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
3.3.1. N-{4-O-[3-O-(4-O-
a
-
L
-rhamnopyranosyl-
b
-
D
-
method (Yu et al., 2013). About 2 mg of each new compound was
dissolved in 2 M HCl (2 mL) and heated at 85 ꢄC for 10 h in oil bath.
The mixture was concentrated under reduced pressure to dryness.
The resulting residue was suspended in H2O and extracted in a
separatory funnel with CHCl3 for three times. The aqueous layer
was evaporated under vacuum, then diluted with H2O, and then re-
evaporated again under vacuum, and with the re-dilution and re-
evaporation procedure being repeated for several times, to
produce a neutral residue.
glucopyranosyl)-
White amorphous powder; ½a D
(MeOH) lmax (log ) 202.4 (3.89), 219.8 (3.78), 272.4 (2.86) nm; IR
(KBr) nmax 3323, 2934, 1640, 1511, 1380, 1230, 1027, 829, 815,
a
-L
-rhamnopyranosyl]-phenethyl}-acetamide (1)
ꢀ
20-82.7 (c 0.071, MeOH); UV
490
491
492
493
494
495
496
e
764 cmꢁ1 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz,
;
DMSO-d6) data see Tables 1 and 2; ESIMS m/z 632.2 [MꢁH]ꢁ;
HRESIMS m/z 634.2701 [M+H]+ (calcd for C28H44NO15, 634.2705)
and 656.2525 [M+Na]+ (calcd for C28H43NNaO15, 656.2525).
Each residue of compounds 1–5 was dissolved in anhydrous
pyridine (1 mL), separately. L-Cysteine methyl ester hydrochloride
497
498
3.3.2. N-methyl-N-{4-O-[3-O-(4-O-
glucopyranosyl)- -rhamnopyranosyl]-phenethyl}-acetamide (2)
White amorphous powder; ½a D
20-104.1 (c 0.18, MeOH); UV
(MeOH) lmax (log ) 203.4 (4.08), 221.6 (3.96), 272.4 (2.98) nm; IR
(KBr) nmax 3397, 2933, 1613, 1510, 1405, 1230, 1065, 1032, 837, 814,
a-L-rhamnopyranosyl-b-D-
(2 mg) was then added, and the reaction mixture was incubated at
60 ꢄC for 2 h. After the mixture was concentrated to dryness under
reduced pressure, 0.2 mL of N-trimethylsilylimidazole was added,
and the mixture was further incubated at 60 ꢄC for 2 h. Then H2O
(2 mL) was added, and the solution was extracted with hexane for
three times (2 mL each). The hexane extract was subjected to GC
under the following conditions: capillary column: HP-5
a-L
499
500
501
502
503
504
505
ꢀ
e
764 cmꢁ1 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz,
;
DMSO-d6) data see Tables 1 and 2; ESIMS m/z 646.2 [MꢁH]ꢁ;
HRESIMS m/z 648.2866 [M+H]+ (calcd for C29H46NO15, 648.2862)
and 670.2677 [M+Na]+ (calcd for C29H45NNaO15, 670.2681).
(30 m ꢃ 0.25 mm, with a 0.25
mm film, Dikma); detection: FID;
detector temperature: 280 ꢄC; injection temperature: 260 ꢄC;
initial temperature 16 ꢄC, which was raised to 280 ꢄC at the rate
of 5 ꢄC/min and the final temperature was maintained for 10 min;
506
507
508
3.3.3. N-methyl-N-{4-O-[3-O-(6-O-benzoyl-4-O-
rhamnopyranosyl- -glucopyranosyl)- -rhamnopyranosyl]-
phenethyl}-acetamide (3)
White amorphous powder; ½a D
(MeOH) lmax (log ) 203.4 (4.22), 224.2 (4.14), 273.4 (3.11) nm; IR
(KBr) nmax 3395, 2933, 1720, 1616, 1510, 1451, 1405, 1275, 1064,
1024, 836, 812, 716 cmꢁ1 1H NMR (500 MHz, DMSO-d6) and 13C
a-L-
b-
D
a-L
Carrier: N2 gas. The authentic monosaccharides,
-rhamnose, were also treated by the same procedure as
compounds 1–5. From the acidic hydrolysates of 1–5, -glucose
and -rhamnose were all confirmed by comparing the retention
times of their derivatives with those of authentic sugars, with the
retention times of -glucose and -rhamnose being 27.96 and
D-glucose and
L
ꢀ
20-87.9 (c 0.14, MeOH); UV
509
510
511
512
513
514
515
516
D
e
L
;
D
L
NMR (125 MHz, DMSO-d6) data see Tables 1 and 2; ESIMS m/z
750.2[MꢁH]ꢁ; HRESIMS m/z 752.3127[M+H]+ (calcd for
C36H50NO16, 752.3124) and 774.2946[M+Na]+ (calcd for
C36H49NNaO16, 774.2944).
22.31 min, respectively.
570
Acknowledgements
517
518
Q9 571
572
3.3.4. N-methyl-N-{4-O-[3-O-(6-O-benzoyl-
-rhamnopyranosyl]-phenethyl}-acetamide (4)
White amorphous powder; ½a D
20-85.1 (c 0.098, MeOH); UV
(MeOH) lmax (log ) 203 (4.39), 223.6 (4.15), 272.8 (3.10) nm; IR
(KBr) nmax 3373, 2922,1719,1615,1510,1451,1405,1276,1064,1019,
834, 715 cmꢁ1 1H NMR (600 MHz, DMSO-d6) and 13C NMR
(150 MHz, DMSO-d6) data see Tables 1 and 2; ESIMS m/z 604.3
[MꢁH]ꢁ; HRESIMS m/z 606.2566[M+H]+ (calcd for C30H40NO12,
606.2545) and 628.2372[M+Na]+ (calcd for C30H39NNaO12,
628.2364).
b-D-glucopyranosyl)-
This work was supported by grants from NSFC
(No. 81361138020) and from the National Science and Technology
Project of China (2012ZX09301002001003).
a-L
573
519
520
521
522
523
524
525
526
ꢀ
e
574
References
;
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
Amakura, Y., Yoshimura, M., Yamakami, S., Yoshida, T., Wakana, D., Hyuga, M.,
Hyuga, S., Hanawa, T., Goda, Y., 2013. Characterization of phenolic constituents
from Ephedra herb extract. Molecules 18, 5326–5334.
Chen, J.J., Chung, C.Y., Hwang, T.L., Chen, J.F., 2009. Amides and benzenoids from
Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and
elastase release by neutrophils. J. Nat. Prod. 72, 107–111.
527
528
529
Committee of the Chinese Pharmacopia, 2010. The Chinese Pharmacopia, vol. 1.
3.3.5. N-methyl-N-{4-O-[3-O-(6-O-trans-cinnamoyl-4-O-
rhamnopyranosyl- -glucopyranosyl)- -rhamnopyranosyl]-
phenethyl}-acetamide (5)
White amorphous powder; ½a D
(MeOH) lmax (log ) 203.4 (4.37), 217.8 (4.30), 278.2 (4.20) nm; IR
(KBr) nmax 3337, 2922, 1731, 1646, 1547, 1374, 1159, 1110, 1053, 898,
a-L-
China Medical Science Press, Beijing, pp. 300–301.
b-
D
a-L
Ding, L.L., Shi, S.S., Cui, J., Wang, S.C., Wang, Z.T., 2006. Advances in research of
chemical constituents and pharmacological activities of Ephedra. China J. Chin.
Mater. Med. 31, 1661–1664.
Konno, C., Mizuno, T., Hikino, H., 1985. Isolation and hypoglycemic activity of
ephedrans A, B, C, D and E, glycans of Ephedra distachya herbs. Planta Med. 51,
162–163.
Wright, A.E., Roth, G.P., Hoffman, J.K., Divlianska, D.B., Pechter, D., Sennett, S.H.,
Guzmán, E.A., Linley, P., McCarthy, P.J., Pitts, T.P., Pomponi, S.A., Reed, J.K., 2009.
Isolation, synthesis, and biological activity of aphrocallistin, an adenine-
substituted bromotyramine metabolite from the hexactinellida sponge
Aphrocallistes Beatrix. J. Nat. Prod. 72, 1178–1183.
Yu, J.Q., Deng, A.J., Wu, L.Q., Zhang, Z.H., Liu, Y., Wang, W.J., Qin, H.L., 2013.
Osteoclast-inhibiting saikosaponin derivatives from Bupleurum Chinense.
Fitoterapia 85, 101–108.
ꢀ
20-114.8 (c 0.099, MeOH); UV
530
531
532
533
534
535
536
e
672 cmꢁ1 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz,
;
DMSO-d6) data see Tables 1 and 2; ESIMS m/z 776.2[MꢁH]ꢁ;
HRESIMS m/z 778.3281 [M+H]+ (calcd for C38H52NO16, 778.3281)
and 800.3104 [M+Na]+ (calcd for C38H51NNaO16, 800.3113).
537
538
3.4. Acid hydrolysis of 1–5 and determination of the absolute
configuration of sugars
Zang, X., Shang, M., Xu, F., Liang, J., Wang, X., Mikage, M., Cai, S., 2013. A-type
proanthocyanidins from the stems of Ephedra sinica (Ephedraceae) and their
antimicrobial activities. Molecules 18, 5172–5189.
539 Q8
The acid hydrolysis of 1–5 and the determination of the
absolute configuration of sugars were performed using reported
Zhao, W., Deng, A.J., Du, G.H., Zhang, J.L., Li, Z.H., Qin, H.L., 2009. Chemical
540
constituents of the stems of Ephedra sinica. J. Asian Nat. Prod. Res. 11, 168–171.
Please cite this article in press as: Zhang, D., et al., N-Substituted acetamide glycosides from the stems of Ephedra sinica. Phytochem. Lett.